AnGes Valuation

AMGXF Stock  USD 0.46  0.00  0.00%   
AnGes is overvalued. AnGes Inc shows a prevailing Real Value of $0.41 per share. The current price of the firm is $0.46. Our model approximates the value of AnGes Inc from examining the firm fundamentals such as Operating Margin of (243.51) %, shares outstanding of 156.07 M, and Return On Equity of -0.43 as well as analyzing its technical indicators and probability of bankruptcy. In general, most investors favor locking in undervalued instruments and disposing overvalued instruments since, at some point in time, asset prices and their ongoing real values will blend.
Overvalued
Today
0.46
Please note that AnGes' price fluctuation is abnormally volatile at this time. Calculation of the real value of AnGes Inc is based on 3 months time horizon. Increasing AnGes' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for AnGes Inc is useful when determining the fair value of the AnGes otc stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of AnGes. Since AnGes is currently traded on the exchange, buyers and sellers on that exchange determine the market value of AnGes OTC Stock. However, AnGes' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.46 Real  0.41 Hype  0.46
The real value of AnGes OTC Stock, also known as its intrinsic value, is the underlying worth of AnGes Inc OTC Stock, which is reflected in its stock price. It is based on AnGes' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of AnGes' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence AnGes' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
0.41
Real Value
3.56
Upside
Estimating the potential upside or downside of AnGes Inc helps investors to forecast how AnGes otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AnGes more accurately as focusing exclusively on AnGes' fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
0.020.463.61
Details

AnGes Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining AnGes's current stock value. Our valuation model uses many indicators to compare AnGes value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AnGes competition to find correlations between indicators driving AnGes's intrinsic value. More Info.
AnGes Inc is number one stock in price to book category among related companies. It is number one stock in price to sales category among related companies fabricating about  3.70  of Price To Sales per Price To Book. Comparative valuation analysis is a catch-all model that can be used if you cannot value AnGes by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AnGes' OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AnGes' earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates AnGes' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in AnGes and how it compares across the competition.

About AnGes Valuation

The otc valuation mechanism determines the current worth of AnGes Inc on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of AnGes Inc. In general, an absolute valuation paradigm, as applied to this otc stock, attempts to find the value of AnGes Inc based exclusively on its fundamental and basic technical indicators. By analyzing AnGes's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of AnGes's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of AnGes. We calculate exposure to AnGes's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to AnGes's related companies.
AnGes, Inc., a biopharmaceutical company, engages in the research and development of gene-based medical products. AnGes, Inc. was founded in 1999 and is headquartered in Ibaraki, Japan. Anges Mg is traded on OTC Exchange in the United States.

8 Steps to conduct AnGes' Valuation Analysis

OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates AnGes' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct AnGes' valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain AnGes' financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine AnGes' revenue streams: Identify AnGes' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research AnGes' industry and market trends, including the size of the market, growth rate, and competition.
  • Establish AnGes' growth potential: Evaluate AnGes' management, business model, and growth potential.
  • Determine AnGes' financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate AnGes' estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the otc stock being valued. We also recomment to seek professional assistance to ensure accuracy.

AnGes Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as AnGes does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding153.1 M
Retained Earnings-12.4 B
Shares Float162.1 M
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AnGes Inc. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for AnGes OTC Stock analysis

When running AnGes' price analysis, check to measure AnGes' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnGes is operating at the current time. Most of AnGes' value examination focuses on studying past and present price action to predict the probability of AnGes' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnGes' price. Additionally, you may evaluate how the addition of AnGes to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Please note, there is a significant difference between AnGes' value and its price as these two are different measures arrived at by different means. Investors typically determine if AnGes is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AnGes' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.